Macrogenics Inc (MGNX)
4.26
-0.21
(-4.70%)
USD |
NASDAQ |
Jun 17, 15:02
Macrogenics 1 Year Total Returns (Daily): -26.36% for June 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 14, 2024 | -26.36% |
| June 13, 2024 | -22.52% |
| June 12, 2024 | -13.67% |
| June 11, 2024 | -11.33% |
| June 10, 2024 | -17.63% |
| June 07, 2024 | -13.71% |
| June 06, 2024 | -10.02% |
| June 05, 2024 | -2.19% |
| June 04, 2024 | -10.29% |
| June 03, 2024 | -7.82% |
| May 31, 2024 | -12.42% |
| May 30, 2024 | -9.21% |
| May 29, 2024 | -18.82% |
| May 28, 2024 | -14.90% |
| May 24, 2024 | -14.95% |
| May 23, 2024 | -17.91% |
| May 22, 2024 | -17.54% |
| May 21, 2024 | -25.91% |
| May 20, 2024 | -25.91% |
| May 17, 2024 | -28.44% |
| May 16, 2024 | -15.65% |
| May 15, 2024 | -27.76% |
| May 14, 2024 | -32.37% |
| May 13, 2024 | -33.43% |
| May 10, 2024 | -54.09% |
| Date | Value |
|---|---|
| May 09, 2024 | 104.3% |
| May 08, 2024 | 102.5% |
| May 07, 2024 | 125.7% |
| May 06, 2024 | 130.2% |
| May 03, 2024 | 127.4% |
| May 02, 2024 | 123.5% |
| May 01, 2024 | 109.9% |
| April 30, 2024 | 114.5% |
| April 29, 2024 | 115.1% |
| April 26, 2024 | 113.5% |
| April 25, 2024 | 116.4% |
| April 24, 2024 | 134.3% |
| April 23, 2024 | 133.5% |
| April 22, 2024 | 121.7% |
| April 19, 2024 | 128.6% |
| April 18, 2024 | 138.1% |
| April 17, 2024 | 136.1% |
| April 16, 2024 | 157.0% |
| April 15, 2024 | 161.0% |
| April 12, 2024 | 175.8% |
| April 11, 2024 | 194.0% |
| April 10, 2024 | 178.2% |
| April 09, 2024 | 146.6% |
| April 08, 2024 | 150.0% |
| April 05, 2024 | 148.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.67%
Minimum
Jun 01 2022
589.3%
Maximum
Mar 16 2021
21.21%
Average
-13.17%
Median
Jan 03 2020
1 Year Total Returns (Daily) Benchmarks
| Moderna Inc | 11.09% |
| Allurion Technologies Inc | -- |
| Novavax Inc | 86.53% |
| Viking Therapeutics Inc | 132.3% |
| Verrica Pharmaceuticals Inc | 28.08% |